Advanced Antihistamine Formulations Strengthen Over-The-Counter Allergy Relief In Ophthalmology Is Playing A Role In Shaping The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market During 2026–2030?
There has been a rapid expansion in the size of the pharmaceutical contract development and manufacturing organization (cmo) market over recent years. This market is projected to expand from $54.73 billion in 2025 to $60.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth has been driven by increasing R&D expenditures by pharmaceutical companies, the rising prevalence of chronic diseases, a surge in generic drug demand, technological advancements in drug manufacturing, and an increasing focus on preclinical and clinical research.
The pharmaceutical contract development and manufacturing organization (cmo) market size is projected to experience substantial growth over the next few years. It is expected to expand to $90.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period can be attributed to the increasing embrace of personalized medicine, a rising demand for biologics and intricate therapeutics, the expansion of CDMO capabilities in developing markets, the integration of digital technologies in drug development, and an increase in strategic partnerships and mergers within the pharmaceutical sector. Significant trends anticipated in the forecast period include the outsourcing of drug development and manufacturing processes, the broadening of CDMO service portfolios, a concentrated focus on regulatory compliance and quality assurance, the formation of strategic alliances between pharmaceutical companies and CDMOs, and the adoption of advanced analytical and testing services.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Which Key Drivers Are Affecting The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Development?
Growing patent expirations are anticipated to boost the pharmaceutical contract development and manufacturing market. This refers to when the legal exclusive rights, allowing an inventor or patent holder to produce, market, or utilize an invention for a set duration, conclude. Pharmaceutical contract development and manufacturing facilitates the rapid creation and manufacturing of generic medications, enabling their market entry once patents expire. For example, data from February 2024, provided by DrugTimes, a Chinese-based company focused on the pharmaceutical and biotech industry, indicates that over 25 products will have lost patent protection by 2037. This could lead to a cumulative revenue reduction surpassing $236.4 billion, measured against 2024 sales. Consequently, the rise in patent expirations is a key driver for the pharmaceutical contract development and manufacturing market.
What Are The Different Segment Types In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segment Breakdown?
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
3) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
What Trends Are Transforming The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies active in the pharmaceutical contract development and manufacturing market are rolling out new services, such as the DevPack, to enhance their service portfolios and cater to the evolving demands of the industry. The DevPack is a service optimized across multiple partners to establish a standardized dataset of development process steps. For instance, in May 2023, ASM Research Chemicals, a Germany-based company that offers contract research and manufacturing services, launched DevPack, a new development pack service specifically for active pharmaceutical ingredients (APIs) manufacturing. This DevPack service, fine-tuned across ten core partners, delivers a standardized dataset for various development processes. It assists in streamlining API research, development, and scale-up. Ideal for CMOs and pharmaceutical firms aiming for quick early-stage manufacturing route development for APIs, the service also supports analytical development and regulatory submissions.
Who Are The Well-Known Companies In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market are Lonza Group, Catalent Inc, WuXi AppTec Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Get The Full Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report:
Which Region Is The Leading Market For The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
